Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Kidney cancer, Renal cell cancer, Secondary cancers
Closed
Phase 3
This trial is comparing a drug called MK-6482 with everolimus for kidney cancer.
It is open to people with kidney cancer that has spread to another part of the body or to the surrounding tissue. And it can’t be removed with surgery.
Recruitment start: 8 October 2020
Recruitment end: 31 December 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Naveed Sarwar
Merck Sharp & Dohme Ltd
Last reviewed: 31 December 2021
CRUK internal database number: 17242
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
